ARL6IP1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 5.61250046438033E-10 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
8.35050029124318E-10 |
Normal-vs-Stage2 |
3.62289999999987E-06 |
Normal-vs-Stage3 |
1.37480027362358E-11 |
Normal-vs-Stage4 |
2.34489999995091E-06 |
Stage1-vs-Stage2 |
4.494800E-01 |
Stage1-vs-Stage3 |
1.920750E-01 |
Stage1-vs-Stage4 |
3.353400E-01 |
Stage2-vs-Stage3 |
1.499770E-01 |
Stage2-vs-Stage4 |
8.576800E-01 |
Stage3-vs-Stage4 |
7.836400E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
1.06910003072613E-09 |
Normal-vs-AfricanAmerican |
1.32139998942904E-09 |
Normal-vs-Asian |
3.057500E-02 |
Caucasian-vs-AfricanAmerican |
2.724400E-01 |
Caucasian-vs-Asian |
8.807000E-01 |
AfricanAmerican-vs-Asian |
5.030600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
6.09090000658341E-10 |
Normal-vs-Female |
3.38410000022549E-09 |
Male-vs-Female |
7.810200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
1.222570E-04 |
Normal-vs-Age(41-60Yrs) |
8.31410496004992E-11 |
Normal-vs-Age(61-80Yrs) |
3.35270033957613E-10 |
Normal-vs-Age(81-100Yrs) |
7.89090004449378E-09 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.364200E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.765000E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.588200E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.595000E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.159800E-02 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.354600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
7.695000E-03 |
Normal-vs-Grade 2 |
2.08890016395458E-10 |
Normal-vs-Grade 3 |
1.08030029366546E-10 |
Normal-vs-Grade 4 |
2.71279999575214E-08 |
Grade 1-vs-Grade 2 |
9.130000E-01 |
Grade 1-vs-Grade 3 |
4.406000E-01 |
Grade 1-vs-Grade 4 |
5.901600E-01 |
Grade 2-vs-Grade 3 |
1.154230E-01 |
Grade 2-vs-Grade 4 |
3.318400E-01 |
Grade 3-vs-Grade 4 |
9.783800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
9.81829995083672E-09 |
Normal-vs-ccB subtype |
2.89599455527423E-11 |
ccA subtype-vs-ccB subtype |
2.359400E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
1.04249942012302E-11 |
Normal-vs-N1 |
2.118000E-02 |
N0-vs-N1 |
3.741400E-01 |
|
|